316 related articles for article (PubMed ID: 28556385)
1. Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study.
Bayart CB; Tamburro JE; Vidimos AT; Wang L; Golden AB
Pediatr Dermatol; 2017 Jul; 34(4):413-421. PubMed ID: 28556385
[TBL] [Abstract][Full Text] [Related]
2. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
Ji Y; Chen S; Yang K; Zhang X; Zhou J; Li L; Xiang B; Qiu T; Dai S; Jiang X; Lu G; Qiu L; Kong F; Zhang Y
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):599-607. PubMed ID: 33856430
[TBL] [Abstract][Full Text] [Related]
4. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
5. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1732-40. PubMed ID: 24011909
[TBL] [Abstract][Full Text] [Related]
6. Propranolol and infantile hemangiomas four years later: a systematic review.
Marqueling AL; Oza V; Frieden IJ; Puttgen KB
Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
[TBL] [Abstract][Full Text] [Related]
7. Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol.
Chen T; Gudipudi R; Nguyen SA; Carroll W; Clemmens C
Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):332-340. PubMed ID: 35466712
[TBL] [Abstract][Full Text] [Related]
8. Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma.
Hermans MM; Rietman AB; Schappin R; de Laat PCJ; Mendels EJ; Breur JMPJ; Langeveld HR; de Wildt SN; Breugem CC; de Graaf M; Raphael MF; Pasmans SGMA
Eur J Pediatr; 2023 Feb; 182(2):757-767. PubMed ID: 36478294
[TBL] [Abstract][Full Text] [Related]
9. Use of propranolol for infantile hemangiomas.
Küpeli S
Pediatr Hematol Oncol; 2012 Apr; 29(3):293-8. PubMed ID: 22303875
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Xue L; Sun C; Xu DP; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
[TBL] [Abstract][Full Text] [Related]
11. Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents.
Hermans MM; Schappin R; de Laat PCJ; Mendels EJ; Breur JMPJ; Langeveld HR; Raphael MF; de Graaf M; Breugem CC; de Wildt SN; Okkerse JME; Pasmans SGMA; Rietman AB
Dermatology; 2024; 240(2):216-225. PubMed ID: 38228125
[TBL] [Abstract][Full Text] [Related]
12. Atenolol: a promising alternative to propranolol for the treatment of hemangiomas.
Raphaël MF; de Graaf M; Breugem CC; Pasmans SGMA; Breur JMPJ
J Am Acad Dermatol; 2011 Aug; 65(2):420-421. PubMed ID: 21763565
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review.
Wang Q; Xiang B; Chen S; Ji Y
Australas J Dermatol; 2019 Aug; 60(3):181-185. PubMed ID: 30515761
[TBL] [Abstract][Full Text] [Related]
14. Use of Propranolol for Treating Hemangiomas in Infants with Previously Diagnosed Hypoglycemic Conditions.
Yang TB; McMahon P; De Léon DD; Treat JR
Pediatr Dermatol; 2016 Nov; 33(6):e381-e384. PubMed ID: 27574111
[TBL] [Abstract][Full Text] [Related]
15. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
[TBL] [Abstract][Full Text] [Related]
17. Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis.
Price CJ; Lattouf C; Baum B; McLeod M; Schachner LA; Duarte AM; Connelly EA
Arch Dermatol; 2011 Dec; 147(12):1371-6. PubMed ID: 21844428
[TBL] [Abstract][Full Text] [Related]
18. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
20. Oral atenolol compared to oral propranolol for infantile hemangioma.
Meza Viteri V; Aranibar L
Medwave; 2023 Dec; 23(11):e2753. PubMed ID: 38061014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
